Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer

Spicer, J, Plunkett, T, Somaiah, N, Chan, S, Kendall, A, Bolunwu, N and Pandha, H (2005) Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer PROSTATE CANCER AND PROSTATIC DISEASES, 8 (4). pp. 364-368.

Full text not available from this repository.

Item Type:	Article
Authors :	Name Email ORCID Spicer, J UNSPECIFIED UNSPECIFIED Plunkett, T UNSPECIFIED UNSPECIFIED Somaiah, N UNSPECIFIED UNSPECIFIED Chan, S UNSPECIFIED UNSPECIFIED Kendall, A UNSPECIFIED UNSPECIFIED Bolunwu, N UNSPECIFIED UNSPECIFIED Pandha, H h.pandha@surrey.ac.uk UNSPECIFIED
Date :	1 December 2005
Identification Number :	https://doi.org/10.1038/sj.pcan.4500821
Uncontrolled Keywords :	Science & Technology, Life Sciences & Biomedicine, Oncology, Urology & Nephrology, ONCOLOGY, UROLOGY & NEPHROLOGY, capecitabine, chemotherapy, PSA, FLUOROURACIL PLUS LEUCOVORIN, METASTATIC COLORECTAL-CANCER, INTRAVENOUS FLUOROURACIL, BREAST-CANCER, FOLINIC ACID, 5-FLUOROURACIL, TRIAL, MITOXANTRONE, THERAPY, PREDNISONE
Related URLs :	Author
Depositing User :	Symplectic Elements
Date Deposited :	17 May 2017 09:31
Last Modified :	17 May 2017 14:43
URI:	http://epubs.surrey.ac.uk/id/eprint/824024

Actions (login required)

View Item

Downloads